Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA +1.16% slid 1.90% to $89.68 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.12% falling 1.71% to 3,789.93 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% falling 1.70% to 30,183.78. This was the stock's second consecutive day of losses. DaVita Inc. closed $35.13 below its 52-week high ($124.81), which the company reached on April 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +1.64% fell 3.02% to $15.41, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH +0.78% fell 3.09% to $213.40, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS -0.12% fell 1.56% to $94.64. Trading volume (591,632) remained 159,036 below its 50-day average volume of 750,668.